These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 19805677)

  • 1. Reporting of time-to-event end points and tracking of failures in randomized trials of radiotherapy with or without any concomitant anticancer agent for locally advanced head and neck cancer.
    Le Tourneau C; Michiels S; Gan HK; Siu LL
    J Clin Oncol; 2009 Dec; 27(35):5965-71. PubMed ID: 19805677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival end point reporting in randomized cancer clinical trials: a review of major journals.
    Mathoulin-Pelissier S; Gourgou-Bourgade S; Bonnetain F; Kramar A
    J Clin Oncol; 2008 Aug; 26(22):3721-6. PubMed ID: 18669458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?
    Bernier J; Cooper JS
    Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.
    Lau H; Phan T; Mackinnon J; Matthews TW
    Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):257-61. PubMed ID: 18347249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
    Colevas AD
    J Clin Oncol; 2006 Jun; 24(17):2644-52. PubMed ID: 16763278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with Mitomycin C and Bleomycin.
    Zakotnik B; Budihna M; Smid L; Soba E; Strojan P; Fajdiga I; Zargi M; Oblak I; Lesnicar H
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):685-90. PubMed ID: 17197122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
    Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ
    Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer.
    Schoenfeld GO; Amdur RJ; Morris CG; Li JG; Hinerman RW; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):377-85. PubMed ID: 18164838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
    Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck.
    Mendenhall WM; Riggs CE; Amdur RJ; Hinerman RW; Villaret DB
    Laryngoscope; 2003 Mar; 113(3):546-51. PubMed ID: 12616212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mcl-1, vascular endothelial growth factor-R2, and 14-3-3sigma expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
    Erovic BM; Pelzmann M; Grasl MCh; Pammer J; Kornek G; Brannath W; Selzer E; Thurnher D
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8632-6. PubMed ID: 16361547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck.
    Matzinger O; Zouhair A; Mirimanoff RO; Ozsahin M
    Clin Oncol (R Coll Radiol); 2009 Sep; 21(7):525-31. PubMed ID: 19535232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
    Siddiqui F; Pajak TF; Watkins-Bruner D; Konski AA; Coyne JC; Gwede CK; Garden AS; Spencer SA; Jones C; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):353-60. PubMed ID: 17889449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
    J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual patients' data meta-analyses in head and neck cancer.
    Bourhis J; Le Maître A; Baujat B; Audry H; Pignon JP; ; ;
    Curr Opin Oncol; 2007 May; 19(3):188-94. PubMed ID: 17414635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHART revisited: a conservative approach for advanced head and neck cancer.
    Saunders M; Rojas AM; Dische S
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):127-33. PubMed ID: 18065214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.